Glibenclamide is an oral hypoglycaemic. It has a long duration of action and the relative risk of prolonged hypoglycaemia is therefore high. It is also relatively contraindicated in renal impairment as active metabolites accumulate.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.